Point72 Asset Management, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (AMLX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
AMLX
Shares outstanding
87.4M shares
Disclosed Ownership
1.05M shares
Ownership
1.2%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 15:52:41 UTC
Date of event
31 Mar 2025
Previous filing
14 Jan 2025
Next filing
25 Jun 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 1.2% 1.05M 0 1.05M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 1.2% 1.05M 0 1.05M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 1.2% 1.05M 0 1.05M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person